Patents by Inventor Pei-Sze Ng

Pei-Sze Ng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclodextrin-Based Polymers for Therapeutic Delivery
    Publication number: 20160058873
    Abstract: Described herein are CDP-therapeutic peptide conjugates, therapeutic delivery systems comprising CDP-therapeutic peptide conjugates, compositions comprising CDP-therapeutic peptide conjugates, dosage forms comprising CDP-therapeutic peptide conjugates, and kits comprising CDP-therapeutic peptide conjugates. Also disclosed are methods of using (e.g., to treat a disorder) the CDP-therapeutic peptide conjugates, therapeutic delivery systems comprising CDP-therapeutic peptide conjugates, compositions comprising CDP-therapeutic peptide conjugates, dosage forms comprising CDP-therapeutic peptide conjugates, and kits comprising CDP-therapeutic peptide conjugates.
    Type: Application
    Filed: March 23, 2015
    Publication date: March 3, 2016
    Inventors: Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Cissy Young
  • CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
    Publication number: 20150209440
    Abstract: Particles and conjugates for delivering nucleic acid agents. Compositions containing the particles, the conjugates, or both. Methods of using the particles, the conjugates, and the compositions.
    Type: Application
    Filed: April 9, 2015
    Publication date: July 30, 2015
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Donald E. Bergstrom
  • POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
    Publication number: 20140328919
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: December 17, 2013
    Publication date: November 6, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Jerry Zhang, Pei-Sze Ng
  • CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
    Publication number: 20140296322
    Abstract: Particles and conjugates for delivering nucleic acid agents. Compositions containing the particles, the conjugates, or both. Methods of using the particles, the conjugates, and the compositions.
    Type: Application
    Filed: April 18, 2014
    Publication date: October 2, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Oliver S. Fetzer, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Jungyeon Hwang, Donald Bergstrom
  • POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
    Publication number: 20140286873
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: October 8, 2013
    Publication date: September 25, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Thomas C. Crawford, Scott Eliasof, Geeti Gangal, Pei-Sze Ng, Lawrence Alan Reiter
  • Cyclodextrin-Based Polymers for Therapeutic Delivery
    Publication number: 20140213504
    Abstract: Described herein are CDP-therapeutic peptide conjugates, therapeutic delivery systems comprising CDP-therapeutic peptide conjugates, compositions comprising CDP-therapeutic peptide conjugates, dosage forms comprising CDP-therapeutic peptide conjugates, and kits comprising CDP-therapeutic peptide conjugates. Also disclosed are methods of using (e.g., to treat a disorder) the CDP-therapeutic peptide conjugates, therapeutic delivery systems comprising CDP-therapeutic peptide conjugates, compositions comprising CDP-therapeutic peptide conjugates, dosage forms comprising CDP-therapeutic peptide conjugates, and kits comprising CDP-therapeutic peptide conjugates.
    Type: Application
    Filed: November 25, 2013
    Publication date: July 31, 2014
    Applicant: Cerulean Pharma Inc.
    Inventors: Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Cissy Young
  • Polymer-Agent Conjugates, Particles, Compositions, and Related Methods of Use
    Publication number: 20140193510
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: February 13, 2014
    Publication date: July 10, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Thomas C Crawford, Geeti Gangal, Lawrence Alan Reiter, Pei-Sze Ng
  • THERAPEUTIC PEPTIDE-POLYMER CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS
    Publication number: 20140135254
    Abstract: Described herein are conjugates (e.g., therapeutic peptide-polymer conjugates and protein-polymer conjugates) and particles, which can be used, for example, in the treatment of a disorder such as cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the conjugates (e.g., therapeutic peptide-polymer conjugates and protein-polymer conjugates) and particles, methods of making the conjugates (e.g., therapeutic peptide-polymer conjugates and protein-polymer conjugates) and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: March 28, 2013
    Publication date: May 15, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson
  • POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
    Publication number: 20140099263
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: March 19, 2013
    Publication date: April 10, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Thomas C. Crawford, Geeti Gangal, Lawrence Alan Reiter, Pei-Sze Ng
  • POLYMER-EPOTHILONE CONJUGATES, PARTICLES, COMPOSITIONS AND RELATED METHODS OF USE
    Publication number: 20140072633
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer or neurological deficits. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: May 29, 2013
    Publication date: March 13, 2014
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Thomas C. Crawford, Geeti Gangal, Lawrence Alan Reiter, Pei-Sze Ng
  • CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS
    Publication number: 20140037573
    Abstract: Particles and conjugates for delivering nucleic acid agents. Compositions containing the particles, the conjugates, or both. Methods of using the particles, the conjugates, and the compositions.
    Type: Application
    Filed: February 21, 2013
    Publication date: February 6, 2014
    Inventors: Scott Eliasof, Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Donald Bergstrom
  • POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
    Publication number: 20130011445
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: July 12, 2012
    Publication date: January 10, 2013
    Inventors: Thomas C. Crawford, Scott Eliasof, Geeti Gangal, Pei-Sze Ng, Lawrence Alan Reiter
  • CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY
    Publication number: 20120302505
    Abstract: Described herein are CDP-therapeutic peptide conjugates, therapeutic delivery systems comprising CDP-therapeutic peptide conjugates, compositions comprising CDP-therapeutic peptide conjugates, dosage forms comprising CDP-therapeutic peptide conjugates, and kits comprising CDP-therapeutic peptide conjugates. Also disclosed are methods of using (e.g., to treat a disorder) the CDP-therapeutic peptide conjugates, therapeutic delivery systems comprising CDP-therapeutic peptide conjugates, compositions comprising CDP-therapeutic peptide conjugates, dosage forms comprising CDP-therapeutic peptide conjugates, and kits comprising CDP-therapeutic peptide conjugates.
    Type: Application
    Filed: April 20, 2012
    Publication date: November 29, 2012
    Inventors: Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Cissy Young
  • CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS
    Publication number: 20120302622
    Abstract: Particles and conjugates for delivering nucleic acid agents. Compositions containing the particles, the conjugates, or both. Methods of using the particles, the conjugates, and the compositions.
    Type: Application
    Filed: April 10, 2012
    Publication date: November 29, 2012
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Donald E. Bergstrom
  • POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
    Publication number: 20120282306
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: July 12, 2012
    Publication date: November 8, 2012
    Inventors: Scott Eliasof, Thomas C. Crawford, Geeti Gangal, Lawrence Alan Reiter, Pei-Sze Ng
  • CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS
    Publication number: 20120225129
    Abstract: Particles and conjugates for delivering nucleic acid agents. Compositions containing the particles, the conjugates, or both. Methods of using the particles, the conjugates, and the compositions.
    Type: Application
    Filed: August 18, 2011
    Publication date: September 6, 2012
    Applicant: CERULEAN PHARMA INC.
    Inventors: Scott Eliasof, Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson, Donald E. Bergstrom
  • THERAPEUTIC PEPTIDE-POLYMER CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS
    Publication number: 20120052097
    Abstract: Described herein are conjugates (e.g., therapeutic peptide-polymer conjugates and protein-polymer conjugates) and particles, which can be used, for example, in the treatment of a disorder such as cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the conjugates (e.g., therapeutic peptide-polymer conjugates and protein-polymer conjugates) and particles, methods of making the conjugates (e.g., therapeutic peptide-polymer conjugates and protein-polymer conjugates) and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: August 18, 2011
    Publication date: March 1, 2012
    Applicant: Cerulean Pharma Inc.
    Inventors: Oliver S. Fetzer, Jungyeon Hwang, Patrick Lim Soo, Pei-Sze Ng, Sonke Svenson
  • POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
    Publication number: 20110268658
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: January 11, 2011
    Publication date: November 3, 2011
    Inventors: Thomas C. Crawford, Scott Eliasof, Geeti Gangal, Pei-Sze Ng, Lawrence Alan Reiter
  • POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
    Publication number: 20110262490
    Abstract: Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles.
    Type: Application
    Filed: March 25, 2011
    Publication date: October 27, 2011
    Inventors: Jerry Zhang, Pei-Sze Ng
  • FORMULATIONS AND METHODS OF USE
    Publication number: 20110237686
    Abstract: The invention relates to the liquid and lyophilized formulations of small particulates, liposomes, and micelles, and methods for making and using the formulations. In particular, at least in some embodiments, the present invention relates to the production and lyophilization of PEGylated nanoparticles, microparticles, micelles, and liposomes for use and administration in to a subject.
    Type: Application
    Filed: March 25, 2011
    Publication date: September 29, 2011
    Applicant: Cerulean Pharma Inc
    Inventors: Pei-Sze Ng, Jerry Zhang